AMX
Asset Logo

Aerometrex Limited

πŸ‡¦πŸ‡Ί ASX

πŸ‘” PROFESSIONAL SERVICES

Compare
Add to watchlist
πŸ‘‘ Overview

πŸ“ˆ Performance

πŸ’΅ Cost

πŸ€“ Advanced

πŸ‘¨β€πŸ‘©β€πŸ‘§β€πŸ‘¦ Community

πŸ“ˆ

-14.06%
Annual Growth

5 years average annual growth

πŸ’΅

$ 500
Minimum Order

Due to regulatory requirements

🌏

4
Pearlers Invested

Since January 2020

πŸ‘‘ Overview

Key information
πŸ”Ž Fund Overview

Aerometrex Ltd. engages in the provision of geospatial solutions and insights for customers. The company is headquartered in Adelaide, South Australia. The company went IPO on 2019-12-10. The firm specializes in providing geospatial solutions and insights for its customers. Its products include MetroMap, LiDAR and 3D visualization models. The company provides an online imagery Web serving application, MetroMap, which offers the Company’s high quality, accurate imagery to a subscriber base. MetroMap fulfills all the quality and accuracy requirements of sophisticated geospatial data users and provides an easy-to-consume product for the corporate market, via a Web browser interface. The company provides an aerial LiDAR surveying service, which accurately maps the ground surface using airborne lasers. The company has developed a 3D modeling and mapping system derived from oblique aerial photographs. The company offers 3D models of the highest resolution (1cm-2cm pixel) and absolute accuracy (5cm in the XY & Z dimensions) derived from aerial platforms. The company operates in two geographical regions, being Australia and the United States of America.

πŸ“ˆ Performance

Price History

-69.00%

1M

1Y

All Time

Graph

Table

Unsure how much or often to invest?
πŸ—“οΈ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out β†’
πŸ’΅ Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out β†’
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out β†’

πŸ’΅ Costs

πŸ’΅

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

πŸ’Ό

N/A
Management Fee

Included in unit price, not charged by Pearler

πŸ’Έ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πŸ’Έ Net fee calculator

πŸ€“ Advanced information

Technical Info

πŸ’° Price*

$0.31

*Price may be up to 24 hours old

πŸ‘©β€πŸ‘©β€πŸ‘¦ Community Insights

How our community is investing

🌏 Pearlers invested in AMX

4

πŸ“Š Total Capital Earnings

$-962.15

πŸ”ƒ Average investment frequency

21 weeks

πŸ’΅ Average investment amount

$1,193

⏰ Last time a customer invested in AMX

90 days
AMX investor breakdown
πŸ’΅ Income of investors

More than 200k

25%

150k - 200k

25%

100k - 150k

50k - 100k

25%

Less than 50k

25%
πŸ‘Ά Age of investors

18 - 25

26 - 34

50%

35 - 90

50%
πŸ™‹ Legal gender of investors

Female

100%

Male

Pearlers who invest in AMX also invest in...

Vanguard Australian Shares Index ETF

VAS

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

πŸ™Œ Performance (5Yr p.a)

3.85%

πŸ“Š Share price

$100.90 AUD

⛳️ DIVERSIFIED

πŸ‡¦πŸ‡Ί AUSTRALIA

🧱 MATERIALS

πŸ’Έ FINANCIALS

Find Out More

Washington H. Soul Pattinson & Co. Ltd. engages in the ownership of shares, coal mining, distribution and retail of pharmaceutical products; and manufacture of building products. The company is headquartered in Sydney, New South Wales and currently employs 51 full-time employees. Its segments include Strategic Investments Portfolio, Large Caps Portfolio, Private Equity Portfolio, Credit Portfolio, Emerging Companies Portfolio and Property Portfolio. The Strategic Investments Portfolio segment includes significant investments in uncorrelated listed companies where it generally has board representation. Large Caps Portfolio segment is an actively managed, Australian listed equities portfolio. The Private Equity Portfolio segment includes long-term investments in unlisted companies to support their future growth. The Credit Portfolio segment includes investments in corporate loans, bonds, and structured instruments. The Emerging Companies Portfolio segment includes investments in attractive, early stage and high growth companies that are listed, about to undertake an Initial Public Offering (IPO) or are at a pre-IPO stage. Property Portfolio segment comprises direct property investments.

πŸ™Œ Performance (5Yr p.a)

9.41%

πŸ“Š Share price

$32.65 AUD

πŸ’Έ FINANCIALS

πŸ“ˆ HIGH PRICE GROWTH

Alcidion Group Ltd. engages in the development and provision of healthcare software products marketed under the Miya, Patientrack, Smartpage and ExtraMed brands. The company is headquartered in Melbourne, Victoria. The company went IPO on 2011-06-24. The firm's principal activities include the development and licensing of its own healthcare software products (Miya Precision and its associated modules, including Miya Observations, Flow, Task Management and PAS), the reselling of selected healthcare software products from its strategic partners and the delivery of product implementation, product support and maintenance, systems integration, and data analysis services to healthcare customers in Australia, New Zealand, and the United Kingdom. Its product, Miya Precision, is a smart clinical solution based on a FHIR-event platform that facilitates multiple clinical and operational applications. The firm's other products include Smartpage, Patientrack, and Silverlink PCS. Smartpage is an advanced smartphone and Web-based system for hospital communication and task management, addressing the requirements of both clinical and non-clinical users.

πŸ™Œ Performance (5Yr p.a)

-14.63%

πŸ“Š Share price

$0.05 AUD

🩺 HEALTH CARE

Bank of Queensland Ltd. engages in the provision of financial services to the community. The company is headquartered in Brisbane, Queensland and currently employs 3,169 full-time employees. The Company’s operating segments include Retail Banking and BOQ Business. The Retail Banking segment provides retail banking solutions to customers through its owner-managed and corporate branch network, third-party intermediaries, and virgin money distribution channels. Its Owner-Managed Branches retail and small and medium enterprises (SME) lending, deposits, credit cards and insurance. Its VMA business include digital home loans, deposits, credit cards, insurance, and superannuation. The BOQ Business segment includes the BOQ branded commercial lending activity, BOQ Finance and BOQ Specialist businesses. The company also provides tailored business banking solutions, including commercial lending, equipment finance and leasing, cashflow finance, foreign exchange, interest rate hedging, transaction banking and deposit solutions for commercial customers. The company operates more than 160 branches across Australia.

πŸ™Œ Performance (5Yr p.a)

-5.45%

πŸ“Š Share price

$6.43 AUD

πŸ’° HIGH DIVIDEND

🏦 BANKING

Commonwealth Bank of Australia engages in the provision of banking and financial services. The company is headquartered in Sydney, New South Wales and currently employs 48,930 full-time employees. The company serves approximately 17 million customers. The firm's segments include Retail Banking Services, Business Banking, Institutional Banking and Markets and New Zealand. Retail Banking Services segment provides banking products and services to personal customers, and banking and advisory services for high-net-worth individuals. Business Banking serves the banking needs of business, corporate and agribusiness customers across the full range of financial service solutions. Institutional Banking and Markets offers a full range of financial services solutions including access to debt capital markets, transaction banking, working capital and risk management. New Zealand includes the banking and funds management businesses operating in New Zealand under the ASB brand.

πŸ™Œ Performance (5Yr p.a)

17.34%

πŸ“Š Share price

$143.85 AUD

🏦 BANKING

βš–οΈ HIGH GOVERNANCE

πŸƒ HIGH ESG SCORE

🌳 ENVIRONMENTAL

πŸ“ˆ HIGH PRICE GROWTH

Want more shares? Try these...

Australian Nutrition and Sports Limited (ANS) is an Australia-based company, which is engaged in providing healthy and nutritional products. The Company is primarily engaged in development and sale of infant formula, dried dairy products, vitamins and protein supplements. The Company develops its own product formulations but does not manufacture any of its products. It outsources the production of its products to various Australian third-party producers. The third-party manufacturers used by ANS includes OmniBlend, which is a producer of ANS ready to drink protein shakes; Sun Health foods is the producer of ANS protein bars; Maltra Foods, which is the producer of ANS protein powder products, and Nature One Dairy, which is engaged in producing of ANS milk formula products. The Company provides its products under three categories: wellness, athlete and infant.

πŸ™Œ Performance (5Yr p.a)

-19.23%

πŸ“Š Share price

$0.01 AUD

πŸ” FOOD PRODUCTS

πŸ“Š Share price

$0.01 AUD

Allegra Medical Technologies Ltd. engages in the designing, prototyping and manufacturing of medical devices and surgical implants. The company is headquartered in Sydney, New South Wales. The company went IPO on 2007-12-05. The firm is engaged in the medical device industry with its pioneering three dimensional (3D)-printed Sr-HT and Sr-HT-Gahnite orthopedic devices. The company holds exclusive ownership of bio ceramic material, along with registered patents and patent applications from the University of Sydney. This material has several applications, including its use as a cervical fusion cage in spinal surgery, offering treatment options for patients. The firm is developing Sr-HT ceramic material to demonstrate the bioactivity required for bone regeneration. Sr-HT-Gahnite features bioactivity, biocompatibility, and mechanical properties suitable for load- bearing orthopedic implants. The primary focus centers on commercializing the Sr-HT Gahnite Bone substitute.

πŸ™Œ Performance (5Yr p.a)

-15.86%

πŸ“Š Share price

$0.03 AUD

🩺 HEALTH CARE

Compare
Add to watchlist